Related Experiment Video
Updated: Jun 18, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
Nephrogenic systemic fibrosis: what internists need to know.
1University of Missouri-Kansas City, USA. darwisht@umkc.edu
Nephrogenic systemic fibrosis (NSF) is a severe condition linked to gadolinium contrast agents in patients with kidney disease. Avoiding gadolinium and managing risk factors are crucial due to the lack of effective treatments.
Area of Science:
- Nephrology
- Radiology
- Dermatology
Background:
- Nephrogenic systemic fibrosis (NSF) is an emerging, potentially fatal condition affecting skin and organs.
- Over 700 global cases reported, with significant concern linking it to gadolinium contrast media.
- Patients with renal insufficiency are at high risk.
Purpose of the Study:
- To highlight the association between gadolinium contrast media and NSF.
- To emphasize the importance of risk factor management and gadolinium avoidance.
- To inform clinicians about the risks and benefits of gadolinium administration in at-risk patients.
Main Methods:
- Review of reported NSF cases and literature on gadolinium contrast agents.
- Analysis of predisposing factors and clinical outcomes.
- Clinical awareness and risk-benefit assessment guidelines.
Main Results:
- Gadolinium-based contrast agents are strongly implicated in NSF development.
- No established effective therapy for NSF exists.
- Risk factors significantly influence NSF incidence.
Conclusions:
- Gadolinium avoidance is the primary strategy for NSF prevention.
- Careful patient selection and risk assessment are vital before gadolinium administration.
- Clinicians must be vigilant regarding NSF risks in patients with chronic kidney disease.
Related Concept Videos
Nephrotic Syndrome I : Introduction
Nephrotic Syndrome III : Nursing Management
Nephrotic Syndrome II : Assessment and Medical Management
Acute Kidney Injury VI: Nursing Management
Chronic Kidney Disease III: Interprofessional Care
Acute Kidney Injury IV: Diagnostic Studies and Prevention